Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

4 results about "Polyadenylation" patented technology

Polyadenylation is the addition of a poly(A) tail to a messenger RNA. The poly(A) tail consists of multiple adenosine monophosphates; in other words, it is a stretch of RNA that has only adenine bases. In eukaryotes, polyadenylation is part of the process that produces mature messenger RNA (mRNA) for translation. It, therefore, forms part of the larger process of gene expression.

Antisense oligonucleotides targeting downstream of the transcripts 3' terminus

PCT designated stageWO2026132147A1Organic active ingredientsDNA/RNA fragmentationPolyadenylationGenetics
The present invention describes that a pre-mRNA molecule, which temporarily exists before polyadenylation-site induced cleavage occurs, can be targeted by RNase H recruiting antisense oligonucleotides downstream of a transcripts 3' terminus to reduce expression levels of target genes from which the RNA polymerization originates.
Owner:F HOFFMANN LA ROCHE & CO AG +1

Single cell 3'end transcriptome variable poly-adenosine acidification analysis method

The invention discloses a single cell 3'end transcriptome variable polyadenylation (APA) analysis method, and belongs to the field of bioinformatics. The analysis process provided by the invention is based on 3'end transcriptome sequencing data of a single cell, combines multiple processes of UMI deduplication, false comparison removal, site merging, internal amplification removal, polyA site removal with few supporting cells, site verification and the like, and can realize efficient detection and quantification of APA at the single cell level. The method is especially suitable for single cell APA analysis of single cell 3'end transcriptome sequencing data, including 3 'end single cell sequencing data after 10x scRNA-Seq cell subset combination, 3' end single cell sequencing data based on a C1 chip, and even full-length transcriptome data.
Owner:HENAN CANCER HOSPITAL

Targeted nuclear RNA splitting and polyadenylation with CRISPR-Cas

ActiveDE602020073316T2HydrolasesDNA/RNA fragmentationPolyadenylationNuclear division
Owner:UNIVERSITY OF ROCHESTER